Aarti Asnani
Research Area · Beth Israel Deaconess Medical Center
Credentials: · · ·
History
- 2011–2014
Cardiovascular Disease
- 2004–2008
Doctor of Medicine
Research
Metabolic signatures of exercise in human plasma
Science Translational Medicine · 2010 · 356 citations
Journal of Clinical Investigation · 2008 · 218 citations
Application of metabolomics to cardiovascular biomarker and pathway discovery
Review · Journal of the American College of Cardiology · 2008 · 172 citations
14 papers
10 papers
9 papers
9 papers
9 papers
9 papers
9 papers
7 papers
Grants
- 2022–2027
Hemopexin as an Early Biomarker of Anthracycline Cardiac Toxicity
National Heart, Lung, and Blood Institute · R01
Contact PI · $3.2M · Beth Israel Deaconess Medical Center
- 2019–2023
CYP1 Inhibition as a New Therapeutic Strategy for Doxorubicin Cardiomyopathy
National Heart, Lung, and Blood Institute · K08
Contact PI · $837K · Beth Israel Deaconess Medical Center
- 2019–2021
Sex-Specific Differences in the Development of Anthracycline Cardiotoxicity
National Heart, Lung, and Blood Institute · R21
Contact PI · $477.5K · Beth Israel Deaconess Medical Center
Clinical trials
- 2022–2029
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Site PI · Recruiting · Phase 3
Massachusetts General Hospital